Defective interfering viruses and their impact on vaccines and viral vectors

Biotechnology Journal

Volumn 10, Issue 5, 2015, Pages 681-689

  Frensing, Timo ^a,b  

^a MAX PLANCK INSTITUTE FOR DYNAMICS OF COMPLEX TECHNICAL SYSTEMS   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Defective interfering particles; Influenza virus; Viral vaccines; Viral vectors; Virus production

Indexed keywords

GENES; VACCINES; VECTORS;

HIGH YIELD; INFLUENZA VIRUS; INNATE IMMUNE RESPONSE; VIRAL GENOME; VIRAL VECTORS; VIRUS PRODUCTIONS; VIRUS REPLICATION;

VIRUSES;

LIVE VACCINE; MEASLES VACCINE; RABIES VACCINE; RNA DIRECTED RNA POLYMERASE; VIRUS VACCINE; VIRUS VECTOR; YELLOW FEVER VACCINE;

BIOTECHNOLOGICAL PROCEDURES; DNA REPLICATION; GENE AMPLIFICATION; GENE DELETION; HELPER VIRUS; IMMUNE RESPONSE; INFLUENZA VIRUS; INNATE IMMUNITY; MEASLES VIRUS; MUMPS VIRUS; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; REVIEW; RNA VIRUS; RUBELLA VIRUS; SATELLITE VIRUS; VIROGENESIS; VIRUS GENOME; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN; YELLOW FEVER VIRUS; ANIMAL; BIOTECHNOLOGY; GENE VECTOR; HUMAN; PHYSIOLOGY; PROCEDURES;

ORTHOMYXOVIRIDAE;

ANIMALS; BIOTECHNOLOGY; GENETIC VECTORS; HELPER VIRUSES; HUMANS; SATELLITE VIRUSES; VIRAL VACCINES; VIRUS REPLICATION;

EID: 84928829819     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201400429     Document Type: Review

References (71)

1. Henle, W., Henle, G., Interference of inactive virus with the propagation of virus of influenza. Science 1943, 98, 87-89.
2. von Magnus, P., Propagation of the PR8 strain of influenza A virus in chick embryos. II. The formation of incomplete virus following inoculation of large doses of seed virus. Acta pathologica et microbiologica Scandinavica 1951, 28, 278-293.
3. von Magnus, P., Incomplete forms of influenza virus. Adv. in Virus Res. 1954, 2, 59-79.
4. Huang, A. S., Baltimore, D., Defective viral particles and viral disease processes. Nature 1970, 226, 325-327.
5. Holland, J. J., Defective interfering rhabdoviruses, in: Wagner, R. R. (Ed.), The Rhabdoviruses, Springer Science+Business Media, New York 1987, pp. 297-360.
6. Barrett, A. D., Dimmock, N. J., Defective interfering viruses and infections of animals. Curr. Top. Microbiol. Immunol. 1986, 128, 55-84.
7. Roux, L., Simon, A. E., Holland, J. J., Effects of defective interfering viruses on virus replication and pathogenesis in vitro and in vivo. Adv. Virus Res. 1991, 40, 181-211.
8. Perrault, J., Origin and replication of defective interfering particles, in: Shatkin, A. J. (Ed.), Initiation Signals in Viral Gene Expression, Springer-Verlag, Berlin 1981, pp. 151-207.
9. Dimmock, N. J., Antiviral activity of defective interfering influenza virus in vivo, in: Myint, S., Taylor-Robinson, D. (Eds.), Viral and other infections of the human respiratory tract, Chapman & Hall, London 1996, pp. 421-445.
10. Lopez, C. B., Defective viral genomes: Critical danger signals of viral infections. J. Virol. 2014, 88, 8720-8723.
11. Weber, M., Weber, F., RIG-I-like receptors and negative-strand RNA viruses: RLRly bird catches some worms. Cytokine Growth Factor Rev. 2014.
12. Dimmock, N. J., The biological significance of defective interfering viruses. Rev. Med. Virol. 1991, 1, 165-176.
13. Marriott, A. C., Dimmock, N. J., Defective interfering viruses and their potential as antiviral agents. Rev. Med. Virol. 2010, 20, 51-62.
14. Dimmock, N. J., Easton, A. J., Defective Interfering Influenza Virus RNAs: Time To Reevaluate Their Clinical Potential as Broad-Spectrum Antivirals? J. Virol. 2014, 88, 5217-5227.
15. Nayak, D. P., Chambers, T. M., Akkina, R. K., Defective-interfering (DI) RNAs of influenza viruses: origin, structure, expression, and interference. Curr. Top. Microbiol. Immunol. 1985, 114, 103-151.
16. Jennings, P. A., Finch, J. T., Winter, G., Robertson, J. S., Does the higher order structure of the influenza virus ribonucleoprotein guide sequence rearrangements in influenza viral RNA? Cell 1983, 34, 619-627.
17. Arranz, R., Coloma, R., Chichon, F. J., Conesa, J. J. et al., The structure of native influenza virion ribonucleoproteins. Science 2012, 338, 1634-1637.
18. Moeller, A., Kirchdoerfer, R. N., Potter, C. S., Carragher, B., Wilson, I. A., Organization of the influenza virus replication machinery. Science 2012, 338, 1631-1634.
19. Saira, K., Lin, X. D., DePasse, J. V., Halpin, R. et al., Sequence analysis of in vivo defective interfering-like RNA of influenza A H1N1 pandemic virus. J. Virol. 2013, 87, 8064-8074.
20. Holland, J. J., Generation and replication of defective viral genomes, in: Fields, B. N. (Ed.), Fields Virology, Raven Press, New York 1985, pp. 77-99.
21. Holland, J. J., Defective viral genomes, in: Fields, B. N., Knipe, D. M. (Eds.), Fields Virology, Raven Press, New York 1990, pp. 151-165.
22. Lazzarini, R. A., Keene, J. D., Schubert, M., The origins of defective interfering particles of the negative-strand RNA viruses. Cell 1981, 26, 145-154.
23. Stark, C., Kennedy, S. I. T., Generation and propagation of defective-interfering particles of Semliki Forest virus in different cell types. Virology 1978, 89, 285-299.
24. Kang, C. Y., Weide, L. G., Tischfield, J. A., Suppression of vesicular stomatitis virus defective interfering particle generation by a function(s) associated with human chromosome 16. J. Virol. 1981, 40, 946-952.
25. Whistler, T., Bellini, W. J., Rota, P. A., Generation of defective interfering particles by two vaccine strains of measles virus. Virology 1996, 220, 480-484.
26. Holland, J. J., Perezvillarreal, L., Breindl, M., Factors Involved in Generation and Replication of Rhabdovirus Defective T Particles. J. Virol. 1976, 17, 805-815.
27. Kingsbury, D. W., Portner, A., On the genesis of incomplete Sendai virions. Virology 1970, 42, 872.
28. Odagiri, T., Tominaga, K., Tobita, K., Ohta, S., An amino acid change in the nonstructural NS2 Protein of an influenza A virus mutant is responsible for the generation of defective interfering (DI) particles by amplifying DI RNAs and suppressing complementary RNA synthesis. J. Gen. Virol. 1994, 75, 43-53.
29. Rouzine, I. M., Weinberger, L. S., Design requirements for interfering particles to maintain coadaptive stability with HIV-1. J. Virol. 2013, 87, 2081-2093.
30. Enami, M., Fukuda, R., Ishihama, A., Transcription and replication of eight RNA segments of influenza virus. Virology 1985, 142, 68-77.
31. Hatada, E., Hasegawa, M., Mukaigawa, J., Shimizu, K., Fukuda, R., Control of influenza virus gene expression: quantitative analysis of each viral RNA species in infected cells. J. Biochem. Tokyo 1989, 105, 537-546.
32. Akkina, R. K., Chambers, T. M., Nayak, D. P., Expression of defective-interfering influenza virus-specific transcripts and polypeptides in infected cells. J. Virol. 1984, 51, 395-403.
33. Duhaut, S. D., McCauley, J. W., Defective RNAs inhibit the assembly of influenza virus genome segments in a segment-specific manner. Virology 1996, 216, 326-337.
34. Frensing, T., Pflugmacher, A., Bachmann, M., Peschel, B., Reichl, U., Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production. Appl. Microbiol. Biotechnol. 2014.
35. Shapiro, G. I., Gurney, T. Jr., Krug, R. M., Influenza virus gene expression: Control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs. J. Virol. 1987, 61, 764-773.
36. Widjaja, I., de Vries, E., Rottier, P. J., de Haan, C. A., Competition between influenza A virus genome segments. PLoS One 2012, 7, e47529.
37. Odagiri, T., Tashiro, M., Segment-specific noncoding sequences of the influenza virus genome RNA are involved in the specific competition between defective interfering RNA and its progenitor RNA segment at the virion assembly step. J. Virol. 1997, 71, 2138-2145.
38. Thomson, M., White, C. L., Dimmock, N. J., The genomic sequence of defective interfering Semliki Forest virus (SFV) determines its ability to be replicated in mouse brain and to protect against a lethal SFV infection in vivo. Virology 1998, 241, 215-223.
39. Kawai, T., Akira, S., Innate immune recognition of viral infection. Nat. Immunol. 2006, 7, 131-137.
40. Haller, O., Kochs, G., Weber, F., The interferon response circuit: induction and suppression by pathogenic viruses. Virology 2006, 344, 119-130.
41. Strahle, L., Garcin, D., Kolakofsky, D., Sendai virus defective-interfering genomes and the activation of interferon-beta. Virology 2006, 351, 101-111.
42. Tapia, K., Kim, W. K., Sun, Y., Mercado-Lopez, X. et al., Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity. PLoS Pathog. 2013, 9, e1003703.
43. Killip, M. J., Young, D. F., Gatherer, D., Ross, C. S. et al., Deep sequencing analysis of defective genomes of parainfluenza virus 5 and their role in interferon induction. J. Virol. 2013, 87, 4798-4807.
44. Graham, B. S., Crowe Jr., J. E., Ledgerwood, J. E., Immunization against viral diseases, in: Knipe, D. M., Howley, P. M. (Eds.), Fields Virology, Wolters Kluwer/Lippincott Williams & Wilkins Health, Philadelphia, PA 2013, pp. 375-413.
45. McLaren, L. C., Holland, J. J., Defective interfering particles from poliovirus vaccine and vaccine reference strains. Virology 1974, 60, 579-583.
46. Bellocq, C., Mottet, G., Roux, L., Wide occurrence of measles virus subgenomic RNAs in attenuated live-virus vaccines. Biologicals 1990, 18, 337-343.
47. Holland, J. J., Villarreal, L. P., Purification of defective interfering T particles of vesicular stomatitis and rabies viruses generated in vivo in brains of newborn mice. Virology 1975, 67, 438-449.
48. Wiktor, T. J., Dietzschold, B., Leamnson, R. N., Koprowski, H., Induction and biological properties of defective interfering particles of rabies virus. J. Virol. 1977, 21, 626-635.
49. Barrett, A. D., Monath, T. P., Cropp, C. B., Adkins, J. A. et al., Attenuation of wild-type yellow fever virus by passage in HeLa cells. J. Gen. Virol. 1990, 71(Pt10), 2301-2306.
50. Calain, P., Roux, L., Generation of measles virus defective interfering particles and their presence in a preparation of attenuated live-virus vaccine. J. Virol. 1988, 62, 2859-2866.
51. Shingai, M., Ebihara, T., Begum, N. A., Kato, A. et al., Differential type I IFN-inducing abilities of wild-type versus vaccine strains of measles virus. J. Immunol. 2007, 179, 6123-6133.
52. Shivakoti, R., Siwek, M., Hauer, D., Schultz, K. L., Griffin, D. E., Induction of dendritic cell production of type I and type III interferons by wild-type and vaccine strains of measles virus: Role of defective interfering RNAs. J. Virol. 2013, 87, 7816-7827.
53. Marcus, P. I., Ngunjiri, J. M., Sekellick, M. J., Wang, L., Lee, C. W., In vitro analysis of virus particle subpopulations in candidate live-attenuated influenza vaccines distinguishes effective from ineffective vaccines. J. Virol. 2010, 84, 10974-10981.
54. Marcus, P. I., Ngunjiri, J. M., Sekellick, M. J., Dynamics of biologically active subpopulations of influenza virus: plaque-forming, noninfectious cell-killing, and defective interfering particles. J. Virol. 2009, 83, 8122-8130.
55. Aggarwal, K., Jing, F., Maranga, L., Liu, J., Bioprocess optimization for cell culture based influenza vaccine production. Vaccine 2011, 29, 3320-3328.
56. Audsley, J. M., Tannock, G. A., The growth of attenuated influenza vaccine donor strains in continuous cell lines. J. Virol. Methods 2005, 123, 187-193.
57. Frensing, T., Heldt, F. S., Pflugmacher, A., Behrendt, I. et al., Continuous influenza virus production in cell culture shows a periodic accumulation of defective interfering particles. PLoS One 2013, 8, e72288.
58. Kool, M., Voncken, J. W., van Lier, F. L., Tramper, J., Vlak, J. M., Detection and analysis of Autographa californica nuclear polyhedrosis virus mutants with defective interfering properties. Virology 1991, 183, 739-746.
59. van Lier, F. L. J., Vandermeijs, W. C. J., Grobben, N. G., Olie, R. A. et al., Continuous beta-galactosidase production with a recombinant baculovirus insect-cell system in bioreactors. J. Biotechnol. 1992, 22, 291-298.
60. Pijlman, G. P., de Vrij, J., van den End, F. J., Vlak, J. M., Martens, D. E., Evaluation of baculovirus expression vectors with enhanced stability in continuous cascaded insect-cell bioreactors. Biotechnol. Bioeng. 2004, 87, 743-753.
61. Giri, L., Feiss, M. G., Bonning, B. C., Murhammer, D. W., Production of baculovirus defective interfering particles during serial passage is delayed by removing transposon target sites in fp25k. J. Gen. Virol. 2012, 93, 389-399.
62. Vera, M., Prieto, J., Strayer, D. S., Fortes, P., Factors influencing the production of recombinant SV40 vectors. Mol. Ther. 2004, 10, 780-791.
63. Frensing, T., Heldt, F. S., Pflugmacher, A., Behrendt, I. et al., Continuous influenza virus production in cell culture shows a periodic accumulation of defective interfering particles. PLoS One 2013, 8.
64. Dimmock, N. J., Dove, B. K., Scott, P. D., Meng, B. et al., Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza A virus and allows protective immunity to be established. PLoS One 2012, 7, e49394.
65. Perez-Cidoncha, M., Killip, M. J., Oliveros, J. C., Asensio, V. J. et al., An unbiased genetic screen reveals the polygenic nature of the influenza virus anti-interferon response. J. Virol. 2014, 88, 4632-4646.
66. Mercado-Lopez, X., Cotter, C. R., Kim, W. K., Sun, Y. et al., Highly immunostimulatory RNA derived from a Sendai virus defective viral genome. Vaccine 2013, 31, 5713-5721.
67. Martinez-Gil, L., Goff, P. H., Hai, R., Garcia-Sastre, A. et al., A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant. J. Virol. 2013, 87, 1290-1300.
68. Easton, A. J., Scott, P. D., Edworthy, N. L., Meng, B. et al., A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo. Vaccine 2011, 29, 2777-2784.
69. Noble, S., McLain, L., Dimmock, N. J., Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing. Vaccine 2004, 22, 3018-3025.
70. White, C. L., Thomson, M., Dimmock, N. J., Deletion analysis of a defective interfering Semliki Forest virus RNA genome defines a region in the nsP2 sequence that is required for efficient packaging of the genome into virus particles. J. Virol. 1998, 72, 4320-4326.
71. Lee, P. K., White, K. A., Construction and characterization of an aureusvirus defective RNA. Virology 2014, 452-453, 67-74.